RxDoctor Payments Data

Loni Jenkins, MD

Family Medicine · Stockbridge, GANPI 1053515338

Payments from drug & device makers

$824in general payments, 2019–2025

Across 50 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$296
  • AstraZeneca$112
  • Kowa Pharmaceuticals America, Inc.$99
  • Boehringer Ingelheim$59
  • Novo Nordisk$56
  • Lilly USA, LLC$51
  • plus $152 from 5 others

What the payments were for

  • Food & beverage$75992%
  • Education$658%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$824 in reported general payments places this provider in the 55th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$37,735
Medicare patients
133
Services billed
482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide73$79,764
JardianceEmpagliflozin35$51,502
EliquisApixaban28$38,232
MounjaroTirzepatide26$30,064
JanuviaSitagliptin Phosphate30$28,115
TrulicityDulaglutide19$25,667
MyrbetriqMirabegron33$16,628
Tresiba Flextouch U-100Insulin Degludec16$14,842
LinzessLinaclotide16$13,772
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,754
Albuterol Sulfate HfaAlbuterol Sulfate57$2,311
Atorvastatin Calcium276$2,186
Lidocaine17$1,879
Diclofenac Sodium60$1,639
Nano 2nd Gen Pen NeedlePen Needle, Diabetic18$1,585

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$56$79,76473 claims
Lilly USA, LLCMounjaro, Trulicity$51$55,73245 claims
Boehringer IngelheimJardiance$59$51,50235 claims
PfizerEliquis$48$38,23228 claims
MerckJanuvia$26$28,11530 claims
Astellas Pharma US IncMyrbetriq$296$16,62833 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Stockbridge

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →